Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy

被引：0
|
作者：
Kefang Liu
Shuguang Tan
Yan Chai
Danqing Chen
Hao Song
Catherine Wei-Hong Zhang
Yi Shi
Jun Liu
Wenjie Tan
Jianxin Lyu
Shan Gao
Jinghua Yan
Jianxun Qi
George F Gao
机构：
[1] College of Laboratory Medicine and Life Sciences,
[2] Wenzhou Medical University,undefined
[3] National Institute for Viral Disease Control and Prevention,undefined
[4] Chinese Center for Disease Control and Prevention (China CDC),undefined
[5] CAS Key Laboratory of Pathogenic Microbiology and Immunology,undefined
[6] Institute of Microbiology,undefined
[7] Chinese Academy of Sciences,undefined
[8] Research Network of Immunity and Health (RNIH),undefined
[9] Beijing Institutes of Life Science,undefined
[10] Chinese Academy of Sciences,undefined
[11] ImmuFucell Biotechnology Co.,undefined
[12] Ltd.,undefined
[13] CAS Key Laboratory of Bio-medical Diagnostics,undefined
[14] Suzhou Institute of Biomedical Engineering and Technology,undefined
[15] Chinese Academy of Sciences,undefined
[16] CAS Key Laboratory of Microbial Physiological and Metabolic Engineering,undefined
[17] Institute of Microbiology,undefined
[18] Chinese Academy of Sciences,undefined
来源：
Cell Research | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：151 / 153
页数：2
相关论文
共 50 条
  • [21] Product review on the Anti-PD-L1 antibody atezolizumab
    Shah, Neil J.
    Kelly, William J.
    Liu, Stephen V.
    Choquette, Karin
    Spira, Alexander
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (02) : 269 - 276
  • [22] Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
    Dirix, Luc Y.
    Takacs, Istvan
    Jerusalem, Guy
    Nikolinakos, Petros
    Arkenau, Hendrik-Tobias
    Forero-Torres, Andres
    Boccia, Ralph
    Lippman, Marc E.
    Somer, Robert
    Smakal, Martin
    Emens, Leisha A.
    Hrinczenko, Borys
    Edenfield, William
    Gurtler, Jayne
    von Heydebreck, Anja
    Grote, Hans Juergen
    Chin, Kevin
    Hamilton, Erika P.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (03) : 671 - 686
  • [23] Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
    Luc Y. Dirix
    Istvan Takacs
    Guy Jerusalem
    Petros Nikolinakos
    Hendrik-Tobias Arkenau
    Andres Forero-Torres
    Ralph Boccia
    Marc E. Lippman
    Robert Somer
    Martin Smakal
    Leisha A. Emens
    Borys Hrinczenko
    William Edenfield
    Jayne Gurtler
    Anja von Heydebreck
    Hans Juergen Grote
    Kevin Chin
    Erika P. Hamilton
    Breast Cancer Research and Treatment, 2018, 167 : 671 - 686
  • [24] Suppression of Endometriosis Using Anti-PD-L1 Antibody
    Mamillapalli, Ramanaiah
    Gawde, Nimisha
    Ucar, Abdullah
    Taylor, Hugh S.
    REPRODUCTIVE SCIENCES, 2023, 30 : 198A - 199A
  • [25] Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
    Su, Xin
    Li, Jian
    Xu, Xiao
    Ye, Youbao
    Wang, Cailiu
    Pang, Guanglong
    Liu, Wenxiu
    Liu, Ang
    Zhao, Changchun
    Hao, Xiangyong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [26] VENTANA anti-PD-L1 (SP263) rabbit monoclonal antibody: A high specificity and sensitivity anti-human PD-L1 antibody
    Quon, Chenglu
    Xia, Xiaoling
    Smith, Margaret
    Drace, Colene
    Mistry, Amita
    Nielsen, Alma
    Sabalos, Costi
    Towne, Penny
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
    Li, Yiwen
    Carpenito, Carmine
    Wang, George
    Surguladze, David
    Forest, Amelie
    Malabunga, Maria
    Murphy, Mary
    Zhang, Yiwei
    Sonyi, Andreas
    Chin, Darin
    Burtrum, Douglas
    Inigo, Ivan
    Pennello, Anthony
    Shen, Leyi
    Malherbe, Laurent
    Chen, Xinlei
    Hall, Gerald
    Haidar, Jaafar N.
    Ludwig, Dale L.
    Novosiadly, Ruslan D.
    Kalos, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [28] The effects of anti-PD-L1 monoclonal antibody on the expression of angiogenesis and invasion-related genes
    Babahan, Cansu
    Abgarmi, Samira Abdi
    Sonugur, Fatma Gizem
    Ocal, Muge
    Akbulut, Hakan
    TURKISH JOURNAL OF BIOLOGY, 2023, 47 (04) : 262 - +
  • [29] Anti-glypican-3 monoclonal antibody (codrituzumab/GC33/RO5137382) treatment enhances tumor infiltration of PD-L1-positive macrophages, and combination therapy with anti-PD-L1 monoclonal antibody promotes antitumor effects
    Endo, Mika
    Kinoshita, Yasuko
    Adachi, Kenji
    Narita, Yoshinori
    Amano, Jun
    Kato, Atsuhiko
    Watanabe, Takeshi
    Kayukawa, Yoko
    Miyazaki, Yoko
    Ohtomo, Toshihiko
    CANCER RESEARCH, 2018, 78 (13)
  • [30] The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy
    Tunger, Antje
    Sommer, Ulrich
    Wehner, Rebekka
    Kubasch, Anne Sophie
    Grimm, Marc-Oliver
    Bachmann, Michael Philipp
    Platzbecker, Uwe
    Bornhaeuser, Martin
    Baretton, Gustavo
    Schmitz, Marc
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
12345